Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism
Background/Objectives: Our objective is to develop hormone-producing pituitary cells that can function in the same manner as the human body and provide more effective treatments than current hormone replacement therapy. We have already established a technique for generating hypothalamic–pituitary or...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Diseases |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-9721/13/4/112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849713627070726144 |
|---|---|
| author | Tatsuma Kondo Hidetaka Suga Kazuhito Takeuchi Yutaro Fuse Yoshiki Sato Toshiaki Hirose Harada Hideyuki Yuichi Nagata Ryuta Saito |
| author_facet | Tatsuma Kondo Hidetaka Suga Kazuhito Takeuchi Yutaro Fuse Yoshiki Sato Toshiaki Hirose Harada Hideyuki Yuichi Nagata Ryuta Saito |
| author_sort | Tatsuma Kondo |
| collection | DOAJ |
| description | Background/Objectives: Our objective is to develop hormone-producing pituitary cells that can function in the same manner as the human body and provide more effective treatments than current hormone replacement therapy. We have already established a technique for generating hypothalamic–pituitary organoids using feeder-free human pluripotent stem cells (hPSCs) and demonstrated their effectiveness in vivo through transplantation into hypopituitary mouse models. To prospectively determine the upper limit of transplanting adenohypophyseal cells into humans, we investigated the human maximum secretion capacity of adrenocorticotropic hormone (ACTH) and growth hormone (GH). Methods: We analyzed data from 28 patients with pituitary adenomas, among whom 16 evinced no abnormality of ACTH secretion and 12 showed no GH secretion on corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone-2 (GHRP-2) stimulation testing. Results: The average ACTH peak value after CRH stimulation tests was 97.2 pg/mL, and the average GH peak value after GHRP-2 stimulation tests was 25.1 ng/mL. Conclusions: These data will likely serve as benchmarks of ACTH and GH secretion when transplanting cultured cells into humans. |
| format | Article |
| id | doaj-art-c697c0183f98475a8b5795ce3d682b6d |
| institution | DOAJ |
| issn | 2079-9721 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diseases |
| spelling | doaj-art-c697c0183f98475a8b5795ce3d682b6d2025-08-20T03:13:54ZengMDPI AGDiseases2079-97212025-04-0113411210.3390/diseases13040112Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative HypopituitarismTatsuma Kondo0Hidetaka Suga1Kazuhito Takeuchi2Yutaro Fuse3Yoshiki Sato4Toshiaki Hirose5Harada Hideyuki6Yuichi Nagata7Ryuta Saito8Department of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya 468-0066, JapanDepartment of Endocrinology and Diabetes, Graduate School of Medicine, Nagoya University, Nagoya 468-0066, JapanDepartment of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya 468-0066, JapanDepartment of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8722, JapanDepartment of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya 468-0066, JapanDepartment of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya 468-0066, JapanDepartment of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya 468-0066, JapanDepartment of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya 468-0066, JapanDepartment of Neurosurgery, Graduate School of Medicine, Nagoya University, Nagoya 468-0066, JapanBackground/Objectives: Our objective is to develop hormone-producing pituitary cells that can function in the same manner as the human body and provide more effective treatments than current hormone replacement therapy. We have already established a technique for generating hypothalamic–pituitary organoids using feeder-free human pluripotent stem cells (hPSCs) and demonstrated their effectiveness in vivo through transplantation into hypopituitary mouse models. To prospectively determine the upper limit of transplanting adenohypophyseal cells into humans, we investigated the human maximum secretion capacity of adrenocorticotropic hormone (ACTH) and growth hormone (GH). Methods: We analyzed data from 28 patients with pituitary adenomas, among whom 16 evinced no abnormality of ACTH secretion and 12 showed no GH secretion on corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone-2 (GHRP-2) stimulation testing. Results: The average ACTH peak value after CRH stimulation tests was 97.2 pg/mL, and the average GH peak value after GHRP-2 stimulation tests was 25.1 ng/mL. Conclusions: These data will likely serve as benchmarks of ACTH and GH secretion when transplanting cultured cells into humans.https://www.mdpi.com/2079-9721/13/4/112pituitary regenerative medicinepituitary glandadrenocorticotropic hormone |
| spellingShingle | Tatsuma Kondo Hidetaka Suga Kazuhito Takeuchi Yutaro Fuse Yoshiki Sato Toshiaki Hirose Harada Hideyuki Yuichi Nagata Ryuta Saito Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism Diseases pituitary regenerative medicine pituitary gland adrenocorticotropic hormone |
| title | Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism |
| title_full | Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism |
| title_fullStr | Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism |
| title_full_unstemmed | Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism |
| title_short | Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism |
| title_sort | benchmark for setting acth cell dosage in clinical regenerative medicine for post operative hypopituitarism |
| topic | pituitary regenerative medicine pituitary gland adrenocorticotropic hormone |
| url | https://www.mdpi.com/2079-9721/13/4/112 |
| work_keys_str_mv | AT tatsumakondo benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism AT hidetakasuga benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism AT kazuhitotakeuchi benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism AT yutarofuse benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism AT yoshikisato benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism AT toshiakihirose benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism AT haradahideyuki benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism AT yuichinagata benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism AT ryutasaito benchmarkforsettingacthcelldosageinclinicalregenerativemedicineforpostoperativehypopituitarism |